-
2
-
-
0002332484
-
Antineoplastic agents
-
Hardmann JG, Limbird LE, Gilman AG, eds. New York: McGraw-Hill
-
Chabner BA, Ryan DP, Paz-Ares L, Garcia-Carbonero R, Calabresi P. 2001. Antineoplastic agents. In: Hardmann JG, Limbird LE, Gilman AG, eds. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill, pp. 1399-404.
-
(2001)
Goodman and Gilman's the Pharmacological Basis of Therapeutics
, pp. 1399-1404
-
-
Chabner, B.A.1
Ryan, D.P.2
Paz-Ares, L.3
Garcia-Carbonero, R.4
Calabresi, P.5
-
3
-
-
33750503424
-
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery
-
Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy- Nissenbauma E, Radovic-Morenob AF, Langer R, Farokhzad OC. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials, 2007;28:869-76.
-
(2007)
Biomaterials
, vol.28
, pp. 869-876
-
-
Cheng, J.1
Teply, B.A.2
Sherifi, I.3
Sung, J.4
Luther, G.5
Gu, F.X.6
Levy- Nissenbauma, E.7
Radovic-Morenob, A.F.8
Langer, R.9
Farokhzad, O.C.C.10
-
4
-
-
53749104543
-
9-Nitrocamptothecin polymeric nanoparticles: Cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats
-
Dadashzadeh S, Derakhshandeh K, HoseiniShirazi F. 9-Nitrocamptothecin polymeric nanoparticles: Cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats. Anti-Cancer Drugs, 2008;19: 805-11.
-
(2008)
Anti-Cancer Drugs
, vol.19
, pp. 805-811
-
-
Dadashzadeh, S.1
Derakhshandeh, K.2
Hoseinishirazi, F.3
-
5
-
-
77950844756
-
Kinetic modeling on drug release from controlled drug delivery systems
-
Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm, 2010; 67(3):217-23.
-
(2010)
Acta Pol Pharm
, vol.67
, Issue.3
, pp. 217-223
-
-
Dash, S.1
Murthy, P.N.2
Nath, L.3
Chowdhury, P.4
-
6
-
-
33947099909
-
Encapsulation of 9- nitrocamptothecin, a novelanticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kinetics
-
Derakhshandeh K, Erfan M, Dadashzadeh S. Encapsulation of 9- nitrocamptothecin, a novelanticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kinetics. Eur J Pharm Biopharm, 2007;66:34-41.
-
(2007)
Eur J Pharm Biopharm
, vol.66
, pp. 34-41
-
-
Derakhshandeh, K.1
Erfan, M.2
Dadashzadeh, S.3
-
7
-
-
79952118825
-
Preparation and in vitro characterization of 9-nitrocamptothecin loaded long circulating nanoparticles for delivery in cancer patients
-
Derakhshandeh K, Soheili M, Dadashzadeh S, Saghiri R. Preparation and in vitro characterization of 9-nitrocamptothecin loaded long circulating nanoparticles for delivery in cancer patients. Int J Nanomedicine, 2010; 5:1-59.
-
(2010)
Int J Nanomedicine
, vol.5
, pp. 1-59
-
-
Derakhshandeh, K.1
Soheili, M.2
Dadashzadeh, S.3
Saghiri, R.4
-
8
-
-
77952691329
-
Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines
-
Ebrahimnejad P, Dinarvand R, Sajadi A, Jaafari MR, Nomani AR, Azizi E, Rad-Malekshahi M, Atyabi F. Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines. Nanomedicine: NBM, 2010;6:478-85.
-
(2010)
Nanomedicine: NBM
, vol.6
, pp. 478-485
-
-
Ebrahimnejad, P.1
Dinarvand, R.2
Sajadi, A.3
Jaafari, M.R.4
Nomani, A.R.5
Azizi, E.6
Rad-Malekshahi, M.7
Atyabi, F.8
-
9
-
-
79951577793
-
Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38
-
Ebrahimnejad P, Dinarvand R, Jafari MR, SajadiTabasi SA, Atyabi F. Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38. Int J Pharm, 2011;406:122-7.
-
(2011)
Int J Pharm
, vol.406
, pp. 122-127
-
-
Ebrahimnejad, P.1
Dinarvand, R.2
Jafari, M.R.3
Sajaditabasi, S.A.4
Atyabi, F.5
-
10
-
-
37349064405
-
PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution
-
Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R. PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution. Int J Pharm, 2008;349:249-55.
-
(2008)
Int J Pharm
, vol.349
, pp. 249-255
-
-
Esmaeili, F.1
Ghahremani, M.H.2
Esmaeili, B.3
Khoshayand, M.R.4
Atyabi, F.5
Dinarvand, R.6
-
11
-
-
39449086491
-
PLGA/PEG derivative polymeric matrix for drug delivery system application: Characterization and cell viability studies
-
Fernandez-Carballoido A, Pastoriza P, Barica E, Montejo C, Negro S. PLGA/PEG derivative polymeric matrix for drug delivery system application: Characterization and cell viability studies. Int J Pharm, 2008;352:50-7.
-
(2008)
Int J Pharm
, vol.352
, pp. 50-57
-
-
Fernandez-Carballoido, A.1
Pastoriza, P.2
Barica, E.3
Montejo, C.4
Negro, S.5
-
12
-
-
0034043034
-
Mechanism of action of methotrexate
-
Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP. Mechanism of action of methotrexate. Immuno Pharmacol, 2000;47: 247-57.
-
(2000)
Immuno Pharmacol
, vol.47
, pp. 247-257
-
-
Genestier, L.1
Paillot, R.2
Quemeneur, L.3
Izeradjene, K.4
Revillard, J.P.5
-
13
-
-
79952093532
-
Preparation and physicochemical characterization of methoteraxtae PLGA microparticles
-
Harsh V, Bharat G, Vishnu A. Preparation and physicochemical characterization of methoteraxtae PLGA microparticles. Int J Pharm Res, 2010;2(1):75-81.
-
(2010)
Int J Pharm Res
, vol.2
, Issue.1
, pp. 75-81
-
-
Harsh, V.1
Bharat, G.2
Vishnu, A.3
-
15
-
-
33847095924
-
Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells
-
Hu Y, Xie J, Tong YW, Wang CH. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J Control Release, 2007;118:7-17.
-
(2007)
J Control Release
, vol.118
, pp. 7-17
-
-
Hu, Y.1
Xie, J.2
Tong, Y.W.3
Wang, C.H.4
-
16
-
-
34249087392
-
PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to SandimmuneNeoral
-
Italia JL, Bhatt DK, Bhardwaj V, Tikoo K, Ravi Kumar MNV. PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to SandimmuneNeoral. J Control Release, 2007;119:197-206.
-
(2007)
J Control Release
, vol.119
, pp. 197-206
-
-
Italia, J.L.1
Bhatt, D.K.2
Bhardwaj, V.3
Tikoo, K.4
Ravi Kumar, M.N.V.5
-
17
-
-
25844461769
-
Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)- folate conjugate
-
Kim SH, Jeong JH, Chun KW, Park TG. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)- folate conjugate. Langmuir, 2005;21:8852-7.
-
(2005)
Langmuir
, vol.21
, pp. 8852-8857
-
-
Kim, S.H.1
Jeong, J.H.2
Chun, K.W.3
Park, T.G.4
-
18
-
-
0034690948
-
Characterization and in vitro release of methotrexate from gelatin: Methotrexate conjugates formed using different preparation variables
-
Kosasih A, Bowman BJ, Wigent RJ, Ofner III CM. Characterization and in vitro release of methotrexate from gelatin: Methotrexate conjugates formed using different preparation variables. Int J Pharm, 2000;204: 81-9.
-
(2000)
Int J Pharm
, vol.204
, pp. 81-89
-
-
Kosasih, A.1
Bowman, B.J.2
Wigent, R.J.3
Ofner III, C.M.4
-
20
-
-
65749087471
-
Methotrexate induces apoptosis in CaSki and NRK cells and influences the organization of their actin cytoskeleton
-
Mazur A, Nowak D, Mannherz HG, Malicka-B?aszkiewicz M. Methotrexate induces apoptosis in CaSki and NRK cells and influences the organization of their actin cytoskeleton. Eur J Pharmacol, 2009; 613:24-33.
-
(2009)
Eur J Pharmacol
, vol.613
, pp. 24-33
-
-
Mazur, A.1
Nowak, D.2
Mannherz, H.G.3
Malicka-Baszkiewicz, M.4
-
21
-
-
0033561495
-
Caspase-mediated cleavage of cytoskeletal actin plays appositive role in the process of morphological apoptosis
-
Mashima T, Naito M, Tsuruo T. Caspase-mediated cleavage of cytoskeletal actin plays appositive role in the process of morphological apoptosis. Oncogene, 1999;18:2423-30.
-
(1999)
Oncogene
, vol.18
, pp. 2423-2430
-
-
Mashima, T.1
Naito, M.2
Tsuruo, T.3
-
22
-
-
80052086444
-
Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system
-
Mohammadi G, Nokhodchi A, Barzegar-Jalali M, Lotfipour F, Adibkia KH, Ehyaei N, Valizadeh H. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system. Colloids Surf B: Biointerfaces, 2011;88: 39-44.
-
(2011)
Colloids Surf B: Biointerfaces
, vol.88
, pp. 39-44
-
-
Mohammadi, G.1
Nokhodchi, A.2
Barzegar-Jalali, M.3
Lotfipour, F.4
Adibkia, K.H.5
Ehyaei, N.6
Valizadeh, H.7
-
24
-
-
30744454813
-
Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates
-
Ofner CM, Pica K, Bowman BJ, Chen CS. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates. Int J Pharm, 2006;308:90-9.
-
(2006)
Int J Pharm
, vol.308
, pp. 90-99
-
-
Ofner, C.M.1
Pica, K.2
Bowman, B.J.3
Chen, C.S.4
-
25
-
-
58649093951
-
Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: Intervention of folic and folinic acid
-
Padmanabhan S, Tripathi DN, Vikram A, Ramarao P, Jena GB. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: Intervention of folic and folinic acid. Mutat Res, 2009;673: 43-52.
-
(2009)
Mutat Res
, vol.673
, pp. 43-52
-
-
Padmanabhan, S.1
Tripathi, D.N.2
Vikram, A.3
Ramarao, P.4
Jena, G.B.5
-
26
-
-
68549132581
-
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
-
Park J, Fong PM, Lu J, Russell KS, Booth CJ, Saltzman WM, Fahmy TM. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine: NBM, 2009;5:410-18.
-
(2009)
Nanomedicine: NBM
, vol.5
, pp. 410-418
-
-
Park, J.1
Fong, P.M.2
Lu, J.3
Russell, K.S.4
Booth, C.J.5
Saltzman, W.M.6
Fahmy, T.M.7
-
27
-
-
0033957359
-
Morphologic and biochemical hallmarks of apoptosis
-
Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res, 2000;45:528-37.
-
(2000)
Cardiovasc Res
, vol.45
, pp. 528-537
-
-
Saraste, A.1
Pulkki, K.2
-
28
-
-
60449106695
-
Methotrexateincorporated polymeric nanoparticles of methoxy poly (ethylene glycol)-grafted chitosan
-
Seo DH, Jeong YI, Kim DG, Jang MJ, Jang MK, Nah JW. Methotrexateincorporated polymeric nanoparticles of methoxy poly (ethylene glycol)-grafted chitosan. Colloids Surf B: Biointerfaces, 2009;69: 157-63.
-
(2009)
Colloids Surf B: Biointerfaces
, vol.69
, pp. 157-163
-
-
Seo, D.H.1
Jeong, Y.I.2
Kim, D.G.3
Jang, M.J.4
Jang, M.K.5
Nah, J.W.6
-
30
-
-
77957827215
-
Nanoparticles of conjugated methotrexate-human serum albumin: Preparation and cytotoxicity evaluations
-
Taheri A, Atyabi F, Salman Nouri F, Ahadi F, Derakhshan MA, Amini M, Ghahremani H, Ostad SN, Mansoori P, Dinarvand R. Nanoparticles of conjugated methotrexate-human serum albumin: Preparation and cytotoxicity evaluations. J Nanomaterials, 2011; 2011:1-7.
-
(2011)
J Nanomaterials
, vol.2011
, pp. 1-7
-
-
Taheri, A.1
Atyabi, F.2
Salman Nouri, F.3
Ahadi, F.4
Derakhshan, M.A.5
Amini, M.6
Ghahremani, H.7
Ostad, S.N.8
Mansoori, P.9
Dinarvand, R.R.10
-
31
-
-
14844303762
-
Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxy xanthone
-
Teixeira M, Alonso MJ, Pinto MM, Barbosa CM. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxy xanthone. Eur J Pharm Biopharm, 2005;59: 491-500.
-
(2005)
Eur J Pharm Biopharm
, vol.59
, pp. 491-500
-
-
Teixeira, M.1
Alonso, M.J.2
Pinto, M.M.3
Barbosa, C.M.4
-
32
-
-
0026670335
-
Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview
-
Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metastasis Rev, 1992;11: 95-103.
-
(1992)
Cancer Metastasis Rev
, vol.11
, pp. 95-103
-
-
Wyllie, A.H.1
|